A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma have?
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma has 2,812 citations in the OpenAlex counts ScholarIQ stores.
When was A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma published?
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma has 2014 year in the ScholarIQ index.
What is the open-access status of A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma?
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma has bronze oa status in the ScholarIQ index.
What is the DOI of A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma?
The DOI for A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma is on the source record.
What is the PMID of A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma?
The PMID for A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma is on the source record.
What is the OpenAlex record for A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma?
The OpenAlex for A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma is on the source record.